أعرض في EDS

Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma according to prior lines of treatment and refractory status: IKEMA subgroup analysis

التفاصيل البيبلوغرافية
العنوان:	Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma according to prior lines of treatment and refractory status: IKEMA subgroup analysis
المؤلفون:	Hajek, Roman Moreau, Philippe Augustson, Bradley Castro, Nelson Pika, Tomas Delimpasi, Sosana de La Rubia, Javier and Maiolino, Angelo Reiman, Tony J. Kryuchkova, Irina and Martinez-Lopez, Joaquin Martin, Thomas G. Mikhael, Joseph and Yong, Kwee Risse, Marie-Laure Asset, Gaelle Marion, Sylvia and Dimopoulos, Meletios A.
سنة النشر:	2021
اللغة:	English
الوصول الحر:	https://explore.openaire.eu/search/publication?articleId=od______2127::e87271c21bb15cefc5d82d2fed7bb594Test https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3196677Test
حقوق:	OPEN
رقم الانضمام:	edsair.od......2127..e87271c21bb15cefc5d82d2fed7bb594
قاعدة البيانات:	OpenAIRE

الوصف
الوصف غير متاح.